Share Price and Basic Stock Data
Last Updated: November 19, 2025, 10:40 pm
| PEG Ratio | -2.68 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Supreme Petrochem Ltd operates in the petrochemicals sector, focusing primarily on polymers. The company’s stock price currently stands at ₹626, with a market capitalization of ₹11,769 Cr. Over the years, Supreme Petrochem has demonstrated a volatile revenue trend, with sales reported at ₹5,287 Cr for the year ending March 2023, slightly declining to ₹5,253 Cr in March 2024. However, TTM sales for the latest period reached ₹5,431 Cr, indicating a recovery. Quarterly sales figures reveal fluctuations, with the highest quarterly sales recorded at ₹1,573 Cr in June 2024, while the lowest was ₹1,180 Cr in December 2022. The company’s operational efficiency is reflected in its ability to maintain a cash conversion cycle (CCC) of just 8 days, showcasing a strong operational framework. Given the competitive landscape, Supreme Petrochem’s performance positions it well within the industry, although it must navigate the challenges posed by fluctuating raw material prices and market demand.
Profitability and Efficiency Metrics
Supreme Petrochem’s profitability metrics indicate a diverse performance landscape. The company reported a net profit of ₹307 Cr for the year ending March 2025, with a net profit margin of 6.48%. This reflects a stable profitability trend despite a decline from ₹663 Cr in March 2022. Operating profit margins (OPM) trended at 9% in March 2025, a decrease from 18.59% in March 2022, suggesting tightening margins amid rising costs. Efficiency metrics such as return on equity (ROE) stood at 17.4%, while return on capital employed (ROCE) was reported at 22.8%, both indicating effective capital utilization. The interest coverage ratio (ICR) is notably high at 48.80x, indicating that the company comfortably meets its interest obligations. However, the operating profit has shown volatility, indicating the need for operational improvements to maintain profitability amidst cost pressures.
Balance Sheet Strength and Financial Ratios
Supreme Petrochem’s balance sheet shows robust financial health with total assets recorded at ₹3,448 Cr and total liabilities at ₹3,065 Cr as of March 2025. The company’s reserves increased to ₹2,182 Cr, reflecting prudent financial management. With borrowings at ₹140 Cr, the company maintains a low debt profile, which supports its strong interest coverage ratio. The price-to-book value (P/BV) ratio is reported at 5.29x, suggesting that the stock is priced at a premium compared to its book value, which stands at ₹118.66 per share. The current ratio of 1.91 and quick ratio of 1.24 indicate sufficient liquidity to cover short-term obligations. However, total liabilities have increased over the years, which could pose risks if not managed effectively. Overall, the balance sheet reflects a solid foundation, although ongoing monitoring of liabilities is essential.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Supreme Petrochem indicates significant promoter confidence, with promoters holding 64.24% of the shares. Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) account for 3.69% and 3.87%, respectively, which is relatively low compared to typical sector standards. The public holding stands at 28.10%, reflecting a diverse shareholder base with 46,388 shareholders. The trend shows a slight uptick in institutional investor confidence, as FIIs have gradually increased their stake from 2.14% in December 2022 to 3.69% in March 2025. This growing interest from institutional investors suggests a positive outlook on the company’s future performance. However, the declining public shareholding from 31.21% in December 2022 to 28.10% in March 2025 may hint at a shift in retail investor sentiment, which could impact future liquidity and market perception.
Outlook, Risks, and Final Insight
Looking ahead, Supreme Petrochem faces a dual-edged scenario. On one hand, the company benefits from strong operational metrics and a robust balance sheet, positioning itself well for potential growth. The recent recovery in sales and profitability metrics provides a promising outlook. However, the company must navigate risks such as volatile raw material prices and changes in market demand, which could impact margins. Furthermore, the increasing total liabilities may pose a long-term risk if not managed judiciously. The stability of the interest coverage ratio is reassuring, but any downturn in sales could challenge this. Ultimately, Supreme Petrochem’s ability to adapt to market dynamics and maintain operational efficiency will be critical in determining its future trajectory in the competitive petrochemical landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Supreme Petrochem Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Fluoro Carbons Ltd | 30.5 Cr. | 15.5 | 19.6/10.8 | 254 | 41.8 | 0.00 % | 1.02 % | % | 10.0 |
| Gujarat Petrosynthese Ltd | 36.9 Cr. | 61.8 | 81.5/52.0 | 19.0 | 85.2 | 0.00 % | 4.45 % | 2.93 % | 10.0 |
| AVI Polymers Ltd | 9.58 Cr. | 23.4 | 23.4/9.89 | 3.14 | 19.5 | 0.00 % | 19.4 % | 15.6 % | 10.0 |
| Supreme Petrochem Ltd | 11,769 Cr. | 626 | 982/518 | 38.3 | 118 | 1.60 % | 22.8 % | 17.4 % | 2.00 |
| Signet Industries Ltd | 161 Cr. | 55.4 | 81.8/39.0 | 7.90 | 80.3 | 0.90 % | 13.7 % | 6.88 % | 10.0 |
| Industry Average | 3,688.29 Cr | 172.51 | 52.59 | 83.12 | 0.86% | 14.57% | 13.10% | 7.55 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,485 | 1,235 | 1,180 | 1,387 | 1,225 | 1,278 | 1,188 | 1,563 | 1,573 | 1,506 | 1,405 | 1,539 | 1,387 |
| Expenses | 1,234 | 1,156 | 1,061 | 1,179 | 1,135 | 1,171 | 1,093 | 1,388 | 1,412 | 1,380 | 1,306 | 1,394 | 1,272 |
| Operating Profit | 252 | 79 | 119 | 208 | 90 | 106 | 95 | 175 | 161 | 125 | 99 | 145 | 115 |
| OPM % | 17% | 6% | 10% | 15% | 7% | 8% | 8% | 11% | 10% | 8% | 7% | 9% | 8% |
| Other Income | 12 | 12 | 14 | 21 | 18 | 16 | 16 | 19 | 23 | 17 | 17 | 19 | 15 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 11 | 11 | 11 | 14 | 14 | 14 | 15 | 16 | 16 | 17 | 17 | 17 | 18 |
| Profit before tax | 252 | 78 | 121 | 215 | 94 | 106 | 92 | 177 | 164 | 122 | 96 | 143 | 109 |
| Tax % | 25% | 24% | 26% | 26% | 26% | 26% | 27% | 26% | 26% | 26% | 26% | 25% | 25% |
| Net Profit | 189 | 60 | 90 | 159 | 69 | 78 | 68 | 132 | 122 | 90 | 71 | 107 | 81 |
| EPS in Rs | 10.06 | 3.18 | 4.78 | 8.47 | 3.68 | 4.15 | 3.60 | 6.99 | 6.49 | 4.80 | 3.79 | 5.68 | 4.30 |
Last Updated: August 1, 2025, 10:50 am
Below is a detailed analysis of the quarterly data for Supreme Petrochem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,387.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,539.00 Cr. (Mar 2025) to 1,387.00 Cr., marking a decrease of 152.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,272.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,394.00 Cr. (Mar 2025) to 1,272.00 Cr., marking a decrease of 122.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 115.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 115.00 Cr., marking a decrease of 30.00 Cr..
- For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 8.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 109.00 Cr.. The value appears to be declining and may need further review. It has decreased from 143.00 Cr. (Mar 2025) to 109.00 Cr., marking a decrease of 34.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
- For Net Profit, as of Jun 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2025) to 81.00 Cr., marking a decrease of 26.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.30. The value appears to be declining and may need further review. It has decreased from 5.68 (Mar 2025) to 4.30, marking a decrease of 1.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:21 am
| Metric | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,264 | 2,653 | 2,068 | 2,919 | 3,027 | 3,194 | 2,724 | 3,185 | 5,032 | 5,287 | 5,253 | 6,023 | 5,431 |
| Expenses | 3,175 | 2,559 | 1,964 | 2,621 | 2,830 | 3,100 | 2,576 | 2,511 | 4,126 | 4,626 | 4,780 | 5,488 | 4,995 |
| Operating Profit | 90 | 93 | 104 | 297 | 196 | 93 | 148 | 674 | 907 | 661 | 473 | 535 | 436 |
| OPM % | 3% | 4% | 5% | 10% | 6% | 3% | 5% | 21% | 18% | 12% | 9% | 9% | 8% |
| Other Income | 6 | 3 | 3 | 7 | 8 | 10 | 12 | 16 | 30 | 59 | 65 | 73 | 60 |
| Interest | 23 | 17 | 5 | 5 | 5 | 4 | 6 | 7 | 7 | 6 | 10 | 15 | 12 |
| Depreciation | 29 | 24 | 17 | 22 | 21 | 23 | 36 | 39 | 42 | 47 | 59 | 68 | 71 |
| Profit before tax | 44 | 56 | 85 | 278 | 179 | 76 | 118 | 644 | 888 | 667 | 468 | 525 | 413 |
| Tax % | 31% | 37% | 33% | 35% | 35% | 35% | 13% | 26% | 25% | 25% | 26% | 26% | |
| Net Profit | 31 | 36 | 57 | 179 | 116 | 49 | 103 | 477 | 663 | 498 | 346 | 391 | 307 |
| EPS in Rs | 1.58 | 1.85 | 2.96 | 9.30 | 6.02 | 2.55 | 5.32 | 25.40 | 35.28 | 26.49 | 18.43 | 20.77 | 16.33 |
| Dividend Payout % | 47% | 41% | 51% | 24% | 37% | 59% | 52% | 30% | 22% | 42% | 49% | 48% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -35.20% | -57.76% | 110.20% | 363.11% | 38.99% | -24.89% | -30.52% | 13.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | -22.56% | 167.96% | 252.90% | -324.11% | -63.88% | -5.64% | 43.53% |
Supreme Petrochem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 17% |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 29% |
| 3 Years: | -17% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 49% |
| 3 Years: | 26% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 29% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:40 pm
Balance Sheet
Last Updated: November 9, 2025, 3:02 pm
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 94 | 38 | 38 | 38 | 38 | 38 |
| Reserves | 268 | 280 | 318 | 486 | 549 | 546 | 577 | 971 | 1,478 | 1,806 | 1,982 | 2,194 | 2,182 |
| Borrowings | 32 | 0 | 0 | 0 | 0 | 0 | 29 | 41 | 37 | 17 | 114 | 130 | 140 |
| Other Liabilities | 587 | 505 | 523 | 548 | 650 | 578 | 552 | 649 | 725 | 870 | 932 | 1,087 | 922 |
| Total Liabilities | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,282 |
| Fixed Assets | 371 | 345 | 333 | 337 | 333 | 331 | 371 | 359 | 337 | 527 | 769 | 813 | 1,486 |
| CWIP | 4 | 4 | 10 | 13 | 10 | 24 | 8 | 9 | 179 | 108 | 233 | 582 | 41 |
| Investments | 0 | 0 | 0 | 0 | 111 | 251 | 135 | 470 | 484 | 563 | 572 | 435 | 235 |
| Other Assets | 608 | 532 | 595 | 780 | 842 | 615 | 741 | 917 | 1,279 | 1,534 | 1,492 | 1,618 | 1,520 |
| Total Assets | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,282 |
Below is a detailed analysis of the balance sheet data for Supreme Petrochem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,182.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,194.00 Cr. (Mar 2025) to 2,182.00 Cr., marking a decrease of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 140.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 130.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 922.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,087.00 Cr. (Mar 2025) to 922.00 Cr., marking a decrease of 165.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,282.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,448.00 Cr. (Mar 2025) to 3,282.00 Cr., marking a decrease of 166.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,486.00 Cr.. The value appears strong and on an upward trend. It has increased from 813.00 Cr. (Mar 2025) to 1,486.00 Cr., marking an increase of 673.00 Cr..
- For CWIP, as of Sep 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 582.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 541.00 Cr..
- For Investments, as of Sep 2025, the value is 235.00 Cr.. The value appears to be declining and may need further review. It has decreased from 435.00 Cr. (Mar 2025) to 235.00 Cr., marking a decrease of 200.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,520.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,618.00 Cr. (Mar 2025) to 1,520.00 Cr., marking a decrease of 98.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,282.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,448.00 Cr. (Mar 2025) to 3,282.00 Cr., marking a decrease of 166.00 Cr..
Notably, the Reserves (2,182.00 Cr.) exceed the Borrowings (140.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 58.00 | 93.00 | 104.00 | 297.00 | 196.00 | 93.00 | 119.00 | 633.00 | 870.00 | 644.00 | 359.00 | 405.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 33 | 50 | 38 | 36 | 33 | 33 | 44 | 30 | 25 | 27 | 24 |
| Inventory Days | 22 | 29 | 37 | 46 | 44 | 31 | 40 | 51 | 29 | 55 | 39 | 50 |
| Days Payable | 60 | 61 | 83 | 65 | 80 | 60 | 74 | 90 | 50 | 66 | 66 | 66 |
| Cash Conversion Cycle | -0 | 1 | 3 | 19 | -0 | 3 | -0 | 4 | 8 | 14 | 0 | 8 |
| Working Capital Days | 1 | 3 | 8 | 22 | 12 | 5 | 5 | 19 | 8 | 19 | 1 | 4 |
| ROCE % | 16% | 19% | 22% | 57% | 30% | 12% | 18% | 72% | 66% | 37% | 22% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HSBC Small Cap Fund - Regular Plan | 3,388,150 | 1.43 | 189.6 | 3,388,150 | 2025-04-22 17:25:19 | 0% |
| HSBC Value Fund | 777,400 | 0.4 | 43.5 | 777,400 | 2025-04-22 17:25:19 | 0% |
| ICICI Prudential Smallcap Fund | 329,871 | 0.26 | 18.46 | 329,871 | 2025-04-22 17:25:19 | 0% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 72,039 | 0.65 | 4.03 | 72,039 | 2025-04-22 17:25:19 | 0% |
| ICICI Prudential S&P BSE 500 ETF | 714 | 0.02 | 0.04 | 714 | 2025-04-22 17:25:19 | 0% |
| HDFC S&P BSE 500 Index Fund | 134 | 0.02 | 0.01 | 134 | 2025-04-22 17:25:19 | 0% |
| HDFC S&P BSE 500 ETF | 28 | 0.02 | 0 | 28 | 2025-04-22 17:25:19 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 4.00 | 10.00 |
| Basic EPS (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.63 |
| Diluted EPS (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.63 |
| Cash EPS (Rs.) | 24.38 | 21.59 | 28.97 | 75.00 | 54.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 118.66 | 107.38 | 98.06 | 161.20 | 113.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 118.66 | 107.38 | 98.06 | 161.20 | 113.26 |
| Dividend / Share (Rs.) | 10.00 | 9.00 | 9.00 | 7.20 | 15.00 |
| Revenue From Operations / Share (Rs.) | 320.32 | 279.37 | 281.17 | 535.23 | 338.77 |
| PBDIT / Share (Rs.) | 32.22 | 28.45 | 38.13 | 99.54 | 73.41 |
| PBIT / Share (Rs.) | 28.60 | 25.28 | 35.66 | 95.09 | 69.25 |
| PBT / Share (Rs.) | 27.94 | 24.90 | 35.46 | 94.43 | 68.47 |
| Net Profit / Share (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.78 |
| PBDIT Margin (%) | 10.05 | 10.18 | 13.56 | 18.59 | 21.66 |
| PBIT Margin (%) | 8.92 | 9.05 | 12.68 | 17.76 | 20.44 |
| PBT Margin (%) | 8.72 | 8.91 | 12.61 | 17.64 | 20.21 |
| Net Profit Margin (%) | 6.48 | 6.59 | 9.42 | 13.18 | 14.99 |
| Return on Networth / Equity (%) | 17.50 | 17.16 | 27.01 | 43.76 | 44.84 |
| Return on Capital Employeed (%) | 22.53 | 21.94 | 35.49 | 56.82 | 57.42 |
| Return On Assets (%) | 11.32 | 11.30 | 18.23 | 29.11 | 27.20 |
| Asset Turnover Ratio (%) | 1.85 | 1.81 | 2.11 | 2.50 | 2.12 |
| Current Ratio (X) | 1.91 | 2.23 | 2.41 | 2.48 | 2.20 |
| Quick Ratio (X) | 1.24 | 1.69 | 1.64 | 2.05 | 1.68 |
| Inventory Turnover Ratio (X) | 6.45 | 5.77 | 6.79 | 8.74 | 5.55 |
| Dividend Payout Ratio (NP) (%) | 45.74 | 48.84 | 33.97 | 23.38 | 7.87 |
| Dividend Payout Ratio (CP) (%) | 38.96 | 41.68 | 31.06 | 22.00 | 7.27 |
| Earning Retention Ratio (%) | 54.26 | 51.16 | 66.03 | 76.62 | 92.13 |
| Cash Earning Retention Ratio (%) | 61.04 | 58.32 | 68.94 | 78.00 | 92.73 |
| Interest Coverage Ratio (X) | 48.80 | 74.07 | 200.52 | 149.99 | 94.93 |
| Interest Coverage Ratio (Post Tax) (X) | 32.46 | 48.98 | 140.30 | 107.29 | 66.68 |
| Enterprise Value (Cr.) | 11337.80 | 11193.68 | 6625.88 | 8246.18 | 3825.67 |
| EV / Net Operating Revenue (X) | 1.88 | 2.13 | 1.25 | 1.64 | 1.20 |
| EV / EBITDA (X) | 18.72 | 20.93 | 9.24 | 8.81 | 5.54 |
| MarketCap / Net Operating Revenue (X) | 1.96 | 2.23 | 1.32 | 1.73 | 1.23 |
| Retention Ratios (%) | 54.25 | 51.15 | 66.02 | 76.61 | 92.12 |
| Price / BV (X) | 5.29 | 5.80 | 3.78 | 5.74 | 3.69 |
| Price / Net Operating Revenue (X) | 1.96 | 2.23 | 1.32 | 1.73 | 1.23 |
| EarningsYield | 0.03 | 0.02 | 0.07 | 0.07 | 0.12 |
After reviewing the key financial ratios for Supreme Petrochem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.38. This value is within the healthy range. It has increased from 21.59 (Mar 24) to 24.38, marking an increase of 2.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.66. It has increased from 107.38 (Mar 24) to 118.66, marking an increase of 11.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.66. It has increased from 107.38 (Mar 24) to 118.66, marking an increase of 11.28.
- For Dividend / Share (Rs.), as of Mar 25, the value is 10.00. This value exceeds the healthy maximum of 3. It has increased from 9.00 (Mar 24) to 10.00, marking an increase of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 320.32. It has increased from 279.37 (Mar 24) to 320.32, marking an increase of 40.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.22. This value is within the healthy range. It has increased from 28.45 (Mar 24) to 32.22, marking an increase of 3.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.60. This value is within the healthy range. It has increased from 25.28 (Mar 24) to 28.60, marking an increase of 3.32.
- For PBT / Share (Rs.), as of Mar 25, the value is 27.94. This value is within the healthy range. It has increased from 24.90 (Mar 24) to 27.94, marking an increase of 3.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For PBDIT Margin (%), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 10.18 (Mar 24) to 10.05, marking a decrease of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 8.92. This value is below the healthy minimum of 10. It has decreased from 9.05 (Mar 24) to 8.92, marking a decrease of 0.13.
- For PBT Margin (%), as of Mar 25, the value is 8.72. This value is below the healthy minimum of 10. It has decreased from 8.91 (Mar 24) to 8.72, marking a decrease of 0.19.
- For Net Profit Margin (%), as of Mar 25, the value is 6.48. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 6.48, marking a decrease of 0.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.50. This value is within the healthy range. It has increased from 17.16 (Mar 24) to 17.50, marking an increase of 0.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.53. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 22.53, marking an increase of 0.59.
- For Return On Assets (%), as of Mar 25, the value is 11.32. This value is within the healthy range. It has increased from 11.30 (Mar 24) to 11.32, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.85. It has increased from 1.81 (Mar 24) to 1.85, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.91, marking a decrease of 0.32.
- For Quick Ratio (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.24, marking a decrease of 0.45.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has increased from 5.77 (Mar 24) to 6.45, marking an increase of 0.68.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 45.74. This value is within the healthy range. It has decreased from 48.84 (Mar 24) to 45.74, marking a decrease of 3.10.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 38.96. This value is within the healthy range. It has decreased from 41.68 (Mar 24) to 38.96, marking a decrease of 2.72.
- For Earning Retention Ratio (%), as of Mar 25, the value is 54.26. This value is within the healthy range. It has increased from 51.16 (Mar 24) to 54.26, marking an increase of 3.10.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 61.04. This value is within the healthy range. It has increased from 58.32 (Mar 24) to 61.04, marking an increase of 2.72.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 48.80. This value is within the healthy range. It has decreased from 74.07 (Mar 24) to 48.80, marking a decrease of 25.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.46. This value is within the healthy range. It has decreased from 48.98 (Mar 24) to 32.46, marking a decrease of 16.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,337.80. It has increased from 11,193.68 (Mar 24) to 11,337.80, marking an increase of 144.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has decreased from 2.13 (Mar 24) to 1.88, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 18.72. This value exceeds the healthy maximum of 15. It has decreased from 20.93 (Mar 24) to 18.72, marking a decrease of 2.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.96, marking a decrease of 0.27.
- For Retention Ratios (%), as of Mar 25, the value is 54.25. This value is within the healthy range. It has increased from 51.15 (Mar 24) to 54.25, marking an increase of 3.10.
- For Price / BV (X), as of Mar 25, the value is 5.29. This value exceeds the healthy maximum of 3. It has decreased from 5.80 (Mar 24) to 5.29, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.96, marking a decrease of 0.27.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Supreme Petrochem Ltd:
- Net Profit Margin: 6.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.53% (Industry Average ROCE: 14.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.5% (Industry Average ROE: 11.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 38.3 (Industry average Stock P/E: 47.81)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Petrochemicals - Polymers | Solitaire Corporate Park, Building No. 11, Mumbai Maharashtra 400093 | investorhelpline@spl.co.in http://www.supremepetrochem.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M P Taparia | Chairperson |
| Mr. Rajan B Raheja | Non Independent Director |
| Mr. B L Taparia | Non Independent Director |
| Mr. S J Taparia | Non Independent Director |
| Mr. Rajeev M Pandia | Independent Director |
| Mr. Akshay R Raheja | Non Independent Director |
| Mr. Anup Kumar Ghosh | Independent Director |
| Mr. Basavaraj N Bankapur | Independent Director |
| Mr. Sanjay R Chougule | Independent Director |
| Ms. Rita A Teaotia | Independent Director |
| Ms. Mona N Desai | Independent Director |
FAQ
What is the intrinsic value of Supreme Petrochem Ltd?
Supreme Petrochem Ltd's intrinsic value (as of 20 November 2025) is 639.17 which is 2.10% higher the current market price of 626.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 11,769 Cr. market cap, FY2025-2026 high/low of 982/518, reserves of ₹2,182 Cr, and liabilities of 3,282 Cr.
What is the Market Cap of Supreme Petrochem Ltd?
The Market Cap of Supreme Petrochem Ltd is 11,769 Cr..
What is the current Stock Price of Supreme Petrochem Ltd as on 20 November 2025?
The current stock price of Supreme Petrochem Ltd as on 20 November 2025 is 626.
What is the High / Low of Supreme Petrochem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Supreme Petrochem Ltd stocks is 982/518.
What is the Stock P/E of Supreme Petrochem Ltd?
The Stock P/E of Supreme Petrochem Ltd is 38.3.
What is the Book Value of Supreme Petrochem Ltd?
The Book Value of Supreme Petrochem Ltd is 118.
What is the Dividend Yield of Supreme Petrochem Ltd?
The Dividend Yield of Supreme Petrochem Ltd is 1.60 %.
What is the ROCE of Supreme Petrochem Ltd?
The ROCE of Supreme Petrochem Ltd is 22.8 %.
What is the ROE of Supreme Petrochem Ltd?
The ROE of Supreme Petrochem Ltd is 17.4 %.
What is the Face Value of Supreme Petrochem Ltd?
The Face Value of Supreme Petrochem Ltd is 2.00.